56
Participants
Start Date
May 20, 2016
Primary Completion Date
July 21, 2021
Study Completion Date
July 21, 2021
Cobimetinib
Cobimetinib tablet or suspension will be administered as per the schedule described in arm description.
Memorial Sloan Kettering Cancer Center, New York
Hôpital de la Timone, Oncologie Pédiatrique, Marseille
Fondazione IRCCS Istituto Nazionale dei Tumori; Struttura Complessa di Pediatria Oncologica, Milan
Hospital Infantil Universitario Nino Jesus, Madrid
Arnold Palmer Hosp-Children, Orlando
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Universitaetsklinikum Muenster, Münster
Schneider Children's Medical Center, Petah Tikva
Arkansas Children'S Hospital, Little Rock
Institut Curie, Oncologie Pédiatrique, Paris
University of Texas Health Science Center at San Antonio, San Antonio
Institut Gustave Roussy; Service Pediatrique, Villejuif
Dana Farber Cancer Institute, Boston
Hospital Universitari Vall d'Hebron, Barcelona
Alderhey Childrens Trust, Liverpool
Great Ormond Street Hospital; Dept. Of Pediatric Oncology, London
The Royal Victoria Infirmary; Paediatric and Adolescent Oncology Unit, Newcastle upon Tyne
Hoffmann-La Roche
INDUSTRY